FTI CONSULTING, INC FCN
Unless otherwise indicated or required by the context, when we use the terms "Company," "FTI Consulting," "we," "us" and "our," we mean FTI Consulting, Inc., a Maryland corporation, and its consolidated subsidiaries.
FTI Consulting is a leading global expert firm for organizations facing crisis and transformation. Individually, each of our segments and practices is staffed with experts recognized for the depth of their knowledge and a track record of making an impact.
•Strategic Communications.
The Company renamed its Corporate Finance & Restructuring segment to Corporate Finance to better align with the segment's business activities, structure and strategy, as of December 31, 2025. The segment name change did not result in any change to the composition of the segment and has no impact on previously reported financial information.
Valuation FY2025 figures against the last close
Where the revenue comes from as reported in the latest 10-K
Revenue by geography
- U.S.
- All other foreign countries
- UK
| Region | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| U.S. | $2.39B | $2.37B | $2.21B |
| All other foreign countries | $888.4M | $844.8M | $808.8M |
| UK | $515.1M | $485.3M | $471.1M |
As the company reported it, from the “Segment Reporting - Revenues Based on Location of Legal Entity (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Regions are the filer's own and are not mapped onto a standard list — one company's “Americas” and another's “United States” are different areas, and making them look comparable would mean making at least one of them wrong. Slices under 1% are folded into “Other”.
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.79B | $3.70B | $3.49B | $3.03B | $2.78B | $2.46B | $2.35B | $2.03B | $1.81B | $1.81B |
| Cost of revenue | $2.57B | $2.52B | $2.35B | $2.07B | $1.92B | $1.67B | $1.53B | $1.33B | $1.22B | $1.21B |
| Gross profit | $1.22B | $1.18B | $1.14B | $962.9M | $860.7M | $788.6M | $817.8M | $699.8M | $592.2M | $599.6M |
| SG&A | $799.6M | $822.2M | $751.3M | $641.1M | $537.8M | $488.4M | $504.1M | $465.6M | $432.0M | $436.7M |
| Total operating expenses | $3.40B | $3.35B | $3.11B | $2.73B | $2.46B | $2.18B | $2.05B | $1.80B | $1.70B | $1.67B |
| Operating income | $389.1M | $347.4M | $377.6M | $303.9M | $312.0M | $282.7M | $305.6M | $226.0M | $108.7M | $142.2M |
| Interest expense | $21.4M | $7.0M | $14.3M | $10.0M | $20.3M | $19.8M | $19.2M | $27.1M | $25.4M | $24.8M |
| Pre-tax income | $371.0M | $350.8M | $358.4M | $297.7M | $297.9M | $262.4M | $288.4M | $207.8M | $87.1M | $127.8M |
| Income tax | $100.1M | $70.7M | $83.5M | $62.2M | $63.0M | $51.8M | $71.7M | $57.2M | $20.9M | $42.3M |
| Net income | $270.9M | $280.1M | $274.9M | $235.5M | $235.0M | $210.7M | $216.7M | $150.6M | $108.0M | $85.5M |
| EPS, basic | 8.33 | 7.96 | 8.10 | 6.99 | 7.02 | 5.92 | 5.89 | 4.06 | 2.79 | 2.09 |
| EPS, diluted | 8.24 | 7.81 | 7.71 | 6.58 | 6.65 | 5.67 | 5.69 | 3.93 | 2.75 | 2.05 |
| Shares, diluted (wtd. avg.) | 32.9M | 35.8M | 35.6M | 35.8M | 35.3M | 37.1M | 38.1M | 38.3M | 39.2M | 41.7M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $265.1M | $660.5M | $303.2M | $491.7M | $494.5M | $295.0M | $369.4M | $312.1M | $190.0M | $216.2M |
| Short-term investments | — | $0 | $25.5M | $0 | — | — | — | — | — | — |
| Receivables | $1.04B | $1.02B | $1.10B | $896.2M | $754.1M | $711.4M | $693.4M | $554.6M | $522.9M | $474.9M |
| Total current assets | $1.52B | $1.82B | $1.56B | $1.51B | $1.37B | $1.13B | $1.18B | $965.4M | $794.2M | $783.2M |
| Property, plant and equipment | $169.3M | $150.3M | $159.7M | $153.5M | $142.2M | $101.6M | $93.7M | $84.6M | $75.1M | $61.9M |
| Goodwill | $1.24B | $1.23B | $1.23B | $1.23B | $1.23B | $1.23B | $1.20B | $1.17B | $1.20B | $1.18B |
| Other intangibles | $13.5M | $16.8M | $18.3M | $25.5M | $32.0M | $41.5M | $38.4M | $34.6M | $44.1M | $52.1M |
| Total assets | $3.49B | $3.60B | $3.33B | $3.24B | $3.10B | $2.78B | $2.78B | $2.38B | $2.26B | $2.23B |
| Accounts payable | $15.0M | $26.0M | $21.7M | $20.3M | $16.2M | $13.1M | $18.3M | $17.7M | $14.1M | $15.8M |
| Short-term debt | — | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total current liabilities | $975.2M | $931.8M | $892.8M | $769.5M | $718.1M | $670.2M | $612.5M | $482.6M | $410.3M | $378.5M |
| Long-term debt | $365.0M | $0 | $0 | $315.2M | $297.2M | $286.1M | $275.6M | $265.6M | $396.3M | $365.5M |
| Total liabilities | $1.76B | $1.34B | $1.34B | $1.56B | $1.52B | $1.38B | $1.29B | $1.03B | $1.07B | $1.02B |
| Retained earnings | $1.86B | $2.39B | $2.11B | $1.86B | $1.70B | $1.51B | $1.41B | $1.20B | $1.05B | $941.0M |
| Total equity | $1.73B | $2.26B | $1.98B | $1.68B | $1.58B | $1.40B | $1.49B | $1.35B | $1.19B | $1.21B |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $152.1M | $395.1M | $224.5M | $188.8M | $355.5M | $327.1M | $217.9M | $230.7M | $147.6M | $233.5M |
| Depreciation and amortisation | $45.8M | $43.9M | $41.1M | $35.9M | $34.3M | $32.6M | $30.1M | $26.2M | $24.4M | $26.7M |
| Stock-based compensation | $39.3M | $38.4M | $29.5M | $25.4M | $23.1M | $22.9M | $18.0M | $15.6M | $16.0M | $16.9M |
| Capital expenditure | $58.5M | $35.4M | $49.5M | $53.3M | $68.7M | $34.8M | $41.8M | $32.3M | $32.0M | $28.9M |
| Investing cash flow | -$58.5M | -$10.2M | -$73.8M | -$60.1M | -$79.1M | -$60.1M | -$60.6M | $18.7M | -$40.6M | -$30.1M |
| Financing cash flow | -$510.5M | -$15.4M | -$354.7M | -$106.0M | -$61.7M | -$360.1M | -$103.3M | -$117.5M | -$140.9M | -$125.3M |
| Buybacks | $858.7M | $10.2M | $21.0M | $85.4M | $46.1M | $353.6M | $105.8M | $55.7M | $168.1M | $21.5M |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-165147.
Plot the figures US dollars
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.81B | $1.81B | $2.03B | $2.35B | $2.46B | $2.78B | $3.03B | $3.49B | $3.70B | $3.79B |
| Gross profit | $599.6M | $592.2M | $699.8M | $817.8M | $788.6M | $860.7M | $962.9M | $1.14B | $1.18B | $1.22B |
| Net income | $85.5M | $108.0M | $150.6M | $216.7M | $210.7M | $235.0M | $235.5M | $274.9M | $280.1M | $270.9M |
Recent filings and events
- Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
- Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
- Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
- New debt or obligation The company has taken on debt or a comparable obligation. Item 2.03
- Regulation FD disclosure Item 7.01
- Shareholder vote The results of the annual meeting or a special vote. Item 5.07
- Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
- Results announced Item 2.02
- Regulation FD disclosure Item 7.01
- Material agreement signed Item 1.01
- New debt or obligation Item 2.03
- Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 8742
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| BAH | Booz Allen Hamilton Holding Corp | $9.42B | 11.4x | -6.4% |
| G | Genpact LTD | $6.86B | 13.0x | 6.6% |
| EXPO | EXPONENT INC | $3.68B | 37.4x | 4.2% |
| HURN | Huron Consulting Group Inc. | $3.17B | 33.5x | 11.9% |
| ASTH | Astrana Health, Inc. | $2.09B | 81.4x | 56.4% |
| ICFI | ICF International, Inc. | $1.69B | 19.1x | -7.3% |
| BWMN | Bowman Consulting Group Ltd. | $742.5M | 58.7x | 14.9% |
| ONT | Onterris, Inc. | $520.8M | — | 19.3% |